Vericel raises 2026 revenue guidance, launches $200 million buyback
Second-quarter revenue rose 22% to $77.5 million as Vericel filed for U.K. authorization of MACI and its board approved the company's first share repurchase program.
SEC filing
1 story
Second-quarter revenue rose 22% to $77.5 million as Vericel filed for U.K. authorization of MACI and its board approved the company's first share repurchase program.
SEC filing